Comparing two types of digital breast imaging for better detection of abnormalities
Comparison of Conspicuity of Masses and Architectural Distortions Between Wide- and Narrow-angle Digital Breast Tomosynthesis Systems
This study is testing whether wide-angle digital breast imaging can find more breast abnormalities than narrow-angle imaging for women getting routine mammograms.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Sex | Female |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT06373354 on ClinicalTrials.gov |
What this trial studies
This study aims to compare the effectiveness of narrow-angle and wide-angle digital breast tomosynthesis (DBT) in detecting masses and architectural distortions in breast tissue. The primary objective is to demonstrate that wide-angle DBT images provide superior visibility of lesions compared to narrow-angle images. Additionally, the study will gather feedback from radiologists and technologists, as well as assess participant comfort during the imaging process. The research is observational and focuses on standard screening mammography patients.
Who should consider this trial
Good fit: Ideal candidates for this study are women undergoing standard screening mammography who can understand and sign consent.
Not a fit: Patients who are pregnant, unable to consent, or male will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved detection of breast abnormalities, enhancing early diagnosis and treatment options for patients.
How similar studies have performed: While this approach is innovative, similar studies have shown promise in improving imaging techniques, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women undergoing standard screening mammography. * Ability to understand and sign consent. Exclusion Criteria: * Pregnant women. * Women unable to consent. * Male patients.
Where this trial is running
Houston, Texas
- MD Anderson Cancer Center — Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Beatriz Adrada, MD — M.D. Anderson Cancer Center
- Study coordinator: Beatriz Adrada, MD
- Email: beatriz.adrada@mdanderson.org
- Phone: (713) 792-2709
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.